SOPH

Sophia Genetics (SOPH)

Sophia Genetics SA

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:SOPH

1 2 3 4 5 6 7 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/21	10 : 09	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:SOPH	Sophia Genetics SA
2024/05/21	10 : 09	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:SOPH	Sophia Genetics SA
2024/05/21	10 : 08	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:SOPH	Sophia Genetics SA
2024/05/21	10 : 08	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:SOPH	Sophia Genetics SA
2024/05/21	10 : 08	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:SOPH	Sophia Genetics SA
2024/05/21	10 : 07	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:SOPH	Sophia Genetics SA
2024/05/20	23 : 02	PR Newswire (US)	SOPHiA GENETICS Announces Instituto Mário Penna as New Customer	NASDAQ:SOPH	Sophia Genetics SA
2024/05/16	19 : 02	PR Newswire (US)	Klinikum Klagenfurt am Wörthersee is Live with SOPHiA GENETICS	NASDAQ:SOPH	Sophia Genetics SA
2024/05/16	00 : 46	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:SOPH	Sophia Genetics SA
2024/05/14	05 : 24	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:SOPH	Sophia Genetics SA
2024/05/07	20 : 01	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:SOPH	Sophia Genetics SA
2024/05/07	19 : 45	GlobeNewswire Inc.	SOPHiA GENETICS Reports First Quarter 2024 Results	NASDAQ:SOPH	Sophia Genetics SA
2024/04/30	20 : 05	GlobeNewswire Inc.	SOPHiA GENETICS to Present at the 2024 RBC Capital Markets Global Healthcare Conference	NASDAQ:SOPH	Sophia Genetics SA
2024/04/23	23 : 29	GlobeNewswire Inc.	SOPHiA GENETICS to Announce Financial Results for First Quarter 2024 on May 7, 2024	NASDAQ:SOPH	Sophia Genetics SA
2024/04/23	18 : 05	PR Newswire (US)	SOPHiA GENETICS Announces Syndicate Bio as First Liquid Biopsy Customer in Africa	NASDAQ:SOPH	Sophia Genetics SA
2024/04/17	19 : 05	PR Newswire (US)	SOPHiA GENETICS Announces Unilabs is using its AI Technology to Detect Homologous Recombination Deficiency (HRD)	NASDAQ:SOPH	Sophia Genetics SA
2024/04/04	14 : 00	PR Newswire (US)	SOPHiA GENETICS and Strand Life Sciences Announce New Strategic Partnership	NASDAQ:SOPH	Sophia Genetics SA
2024/04/04	14 : 00	PR Newswire (US)	SOPHiA GENETICS and Strand Life Sciences Announce New Strategic Partnership	NASDAQ:SOPH	Sophia Genetics SA
2024/04/02	23 : 00	PR Newswire (US)	Laboratorio Barnafi-Krause is Live on SOPHiA DDM™	NASDAQ:SOPH	Sophia Genetics SA
2024/03/20	23 : 00	PR Newswire (US)	SOPHiA GENETICS Announces First Homologous Recombination Deficiency (HRD) Customer in Canada	NASDAQ:SOPH	Sophia Genetics SA
2024/03/15	19 : 00	PR Newswire (US)	SOPHiA GENETICS and The French Kidney Cancer Research Network (UroCCR) Publish Results from Multiyear Collaboration	NASDAQ:SOPH	Sophia Genetics SA
2024/03/08	02 : 07	GlobeNewswire Inc.	SOPHiA GENETICS to Present at the Barclays 26th Annual Global Healthcare Conference	NASDAQ:SOPH	Sophia Genetics SA
2024/03/05	21 : 02	Edgar (US Regulatory)	Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]	NASDAQ:SOPH	Sophia Genetics SA
2024/03/05	21 : 00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:SOPH	Sophia Genetics SA
2024/03/05	20 : 45	GlobeNewswire Inc.	SOPHiA GENETICS Reports Fourth Quarter and Full Year 2023 Results	NASDAQ:SOPH	Sophia Genetics SA
2024/02/22	22 : 45	GlobeNewswire Inc.	SOPHiA GENETICS to Participate in Fireside Chat at the 44th Annual TD Cowen Health Care Conference	NASDAQ:SOPH	Sophia Genetics SA
2024/02/21	00 : 46	GlobeNewswire Inc.	SOPHiA GENETICS to Announce Financial Results for the Fourth Quarter and Full-Year 2023 on March 5, 2024	NASDAQ:SOPH	Sophia Genetics SA
2024/02/07	21 : 31	PR Newswire (US)	SOPHiA GENETICS and AstraZeneca Spain Commit to Increasing Ovarian Cancer Testing in Spain	NASDAQ:SOPH	Sophia Genetics SA
2024/02/07	20 : 51	PR Newswire (US)	SOPHiA GENETICS and AstraZeneca Spain Commit to Increasing Ovarian Cancer Testing in Spain	NASDAQ:SOPH	Sophia Genetics SA
2024/01/26	00 : 50	PR Newswire (US)	SOPHiA GENETICS Supports Genetic Testing in Brazil	NASDAQ:SOPH	Sophia Genetics SA